AACR news: New target plus new drug equals death of melanoma cells

Mer is overexpressed in melanoma and the investigational drug UNC1062 blocks Mer survival signaling in these cells, killing them

2013-04-09

(Press-News.org) Collaborative research presented by the University of Colorado Cancer Center, the University of North Carolina at Chapel Hill, Harvard Medical School and the University of Pittsburgh, at the American Association for Cancer Research (AACR) Annual Conference, shows that the protein receptor Mer is overexpressed in melanoma and that the investigational drug UNC1062 blocks Mer survival signaling in these cells, killing them.

"It's exciting in that Mer receptor expression correlates so perfectly with disease progression. It's tiered – you see a bump in expression as you transition from nevus to melanoma and then again as you transition from melanoma to metastatic disease," says Doug Graham, MD, PhD, investigator at the CU Cancer Center and associate professor of Pediatrics and Immunology at the University of Colorado School of Medicine, the paper's senior author.

After proving this correlation between Mer receptor expression and disease stage in melanoma tissues from clinical patient samples, Graham and colleagues wondered what would happen if they interrupted this Mer signaling. Luckily, the University of North Carolina had recently developed a new compound that did just that – UNC1062. The results were dramatic.

"We showed decreased survival signaling, increased apoptosis and decreased growth of the melanoma cells in dishes and in mouse models," Graham says. It seems that Mer receptors are not only correlated with melanoma progression but are in fact driving the aggressiveness of the disease.

"This is the first time there's been an association between Mer and melanoma and the first time to report about this new drug," Graham says. ### END

ELSE PRESS RELEASES FROM THIS DATE:

AACR news: Rigosertib Phase 1 results lead to disease-focused Phase 2 development

2013-04-09

Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This is the first trial in which orally administered Rigosertib, a dual kinase inhibitor, was studied in solid tumors. Intravenously rigosertib is already in phase 3 clinical trials for myelodysplastic syndrome and pancreatic cancer and oral rigosertib is being studied in a pair of Phase II trials in lower-risk transfusion dependent MDS patients. The drug ...

AACR news: Little molecule makes big difference in bladder cancer metastasis

2013-04-09

In order to kill, bladder cancer must metastasize, most commonly to the lung – what are the differences between bladder cancers that do and do not make this deadly transition? Research presented by the Director of the University of Colorado Cancer Center at the AACR Annual Meeting 2013 shows that one big difference is a little molecule known as hsa-miR-146a. Messenger RNA or mRNA carries gene blueprints to sites where the plans are read and made into proteins, and to a large degree microRNA or miRNA tells mRNA what to do. Theodorescu's work shows that in 256 samples of ...

AACR news: Six2 homeoprotein allows breast cancer cells to detach and metastasize

2013-04-09

In results presented at the AACR Annual Meeting 2013, researchers from the University of Colorado Cancer Center show that the Six2 homeoprotein, while not involved in primary tumor growth, allows cells to detach from substrate and survive their transition through the bloodstream to faraway sites of metastasis. "Here we show for the first time that Six2 causes breast cancer progression. It's this metastasis, especially to the lung, that can eventually be deadly and so perhaps even more so than affecting the size of the primary tumor, we are especially excited to present ...

1-2 punch could be key in treating blindness

2013-04-09

EAST LANSING, Mich. — Researchers have discovered that using two kinds of therapy in tandem may be a knockout combo against inherited disorders that cause blindness. While their study focused on man's best friend, the treatment could help restore vision in people, too. Published in the journal Molecular Therapy, the study builds on earlier work by Michigan State University veterinary ophthalmologist András Komáromy and colleagues. In 2010, they restored day vision in dogs suffering from achromatopsia, an inherited form of total color blindness, by replacing the mutant ...

High pressure gold nanocrystal structure revealed

2013-04-09

A major breakthrough in measuring the structure of nanomaterials under extremely high pressure has been made by researchers at the London Centre for Nanotechnology (LCN). Described in Nature Communications, the study used new advances in x-ray diffraction to image the changes in morphology of gold nanocrystals under pressures of up to 6.5 gigapascals. Under high pressures, imaging methods such as electron or atomic force microscopy are not viable, making x-ray diffraction imaging the only option. However, until recently, focusing an image created with this method ...

Nanotechnology imaging breakthrough

2013-04-09

Washington, D.C.— A team of researchers has made a major breakthrough in measuring the structure of nanomaterials under extremely high pressures. For the first time, they developed a way to get around the severe distortions of high-energy X-ray beams that are used to image the structure of a gold nanocrystal. The technique, described in April 9, 2013, issue of Nature Communications, could lead to advancements of new nanomaterials created under high pressures and a greater understanding of what is happening in planetary interiors. Lead author of the study, Wenge Yang ...

Dedicated cleaning staff shown to reduce C. difficile contamination in hospital rooms

2013-04-09

With rates and deaths associated with Clostridium difficile (C. difficile) at historically high levels, many hospitals have taken extra steps to reduce these infections. New research finds that a dedicated daily cleaning crew who adequately clean and disinfect rooms contaminated by C. difficile using a standardized process can be more effective than other disinfection interventions. The study is published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), in a special topic issue focused ...

Decontamination of unused medical supplies reduces health-care costs

2013-04-09

CHICAGO (April 9, 2013)– In rooms of patients with multidrug-resistant organisms (MDROs), the outside of the packages containing sterile items can become contaminated. Unused medical supplies are often thrown away to prevent the items from becoming pathways for transmission of drug-resistant microbes, and in the process this leads to increased healthcare costs. Researchers at Johns Hopkins Hospital found that hydrogen peroxide vapor (HPV) is an effective way to sanitize the outside of the packages of these sterile supplies. In addition to protecting patients, use of ...

Copper surfaces reduce the rate of health care-acquired infections in the ICU

2013-04-09

CHICAGO (April 9, 2013)– Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half, according to a new study published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, in a special topic issue focused on the role of the environment in infection prevention. In the United States, HAIs result in 100,000 deaths annually and add an estimated $45 billion to healthcare costs. HAIs often contaminate ...

Sea level rise: Jeopardy for terrestrial biodiversity on islands

2013-04-09

Terrestrial species on low-lying islands and coastal regions are vulnerable to sea level rise due to climate-change, the most vulnerable species being endemics with limited ranges and rare species that are endangered already. That is the key message of a study by Florian Wetzel and colleagues of the Konrad Lorenz Institute of Ethology (KLIVV) of the University of Veterinary Medicine, Vienna (Vetmeduni Vienna) and Walter Jetz of the Department of Ecology and Evolutionary Biology at Yale University, USA. The new study is the first of its kind in terms of geographic scope ...

AACR news: New target plus new drug equals death of melanoma cells

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: